PRMT1 and hepatocellular carcinoma: PRMT1-mediated phosphoglycerate dehydrogenase methylation can promote serine accumulation in hepatocellular carcinoma [12], and can enhance glycolysis in hepatocellular carcinoma cells and promote the progression of liver cancer by methylating thymidine kinase and remodeling the actin cytoskeleton [13, 14].